Prosecution Insights
Last updated: October 02, 2026

Examiner: GEIGER, RACHAEL L

Tech Center 3700 • Art Units: 3771 3773 3774

This examiner grants 82% of resolved cases

Analysis

Rachael L. Geiger, an examiner in Tech Center 3700 and Art Unit 3771, has 124 resolved cases. The allowance rate is 82.3%, which is very high and favorable for applicants. This high success rate suggests that the majority of applications reach a grant under this examiner's review, providing a streamlined path to patent issuance.

The interview lift is 18.3%, indicating that interviews are a productive way to address examiner concerns and further increase the likelihood of an allowance. Oral advocacy can help clarify complex issues and move the application toward a grant more effectively than written correspondence alone. Practitioners should consider scheduling an interview to resolve any outstanding rejections.

The median days to allowance is 1018. This timeline is standard for the tech center, indicating that the process follows a typical procedural schedule of approximately three years. The combination of a high allowance rate and a positive interview lift makes this a favorable environment for patent prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

82.3%
Allow Rate
+12.3% vs TC avg
158
Total Applications
+18.3%
Interview Lift
1018
Avg Prosecution Days
Based on 124 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
36.8%
§102 Novelty
49.3%
§103 Obviousness
10.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18941378 ARTICULATION LOCKING MECHANISMS FOR END EFFECTORS AND METHODS OF USE Non-Final OA Boston Scientific Scimed, Inc
18615229 SAFETY LANCET TRANSSEPTAL NEEDLE Final Rejection Boston Scientific Scimed, Inc.
19111435 TROCAR INCLUDING CANNULA Final Rejection CILAG GMBH INTERNATIONAL
17985539 MEDICAL CLIP AND METHOD FOR PRODUCING A MEDICAL IMPLANT Non-Final OA Aesculap AG
18361637 CARDIAC ANCHORING SOLUTIONS Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18798672 Medical Device Delivery System With Locking System Final Rejection Evalve, Inc.
18752514 LYMPHATIC ANASTOMOSIS DEVICES AND METHODS Non-Final OA Beth Israel Deaconess Medical Center, Inc.
17133277 LYMPHATIC ANASTOMOSIS DEVICES AND METHODS Non-Final OA Beth Israel Deaconess Medical Center, Inc.
19072516 CARTRIDGE SYSTEM Non-Final OA OLYMPUS MEDICAL SYSTEMS CORP.
18411596 BENDABLE CLIP DEVICE Final Rejection OLYMPUS MEDICAL SYSTEMS CORP.
19057179 DEFLECTABLE DELIVERY SYSTEM FOR IMPLANT DELIVERY Non-Final OA Medtronic, Inc.
17619452 CONTINUOUS TETHERED TISSUE ANCHOR AND ASSOCIATED SYSTEMS AND METHODS Non-Final OA W. L. Gore & Associates, Inc.
18591252 MEDICAL GRASPING DEVICE WITH SLIDE ACTUATOR Non-Final OA Merit Medical Systems, Inc.
18443087 SOFT TISSUE BIOPSY OR EXCISIONAL DEVICES AND METHODS Non-Final OA Transmed7, LLC
18703100 SUBCUTANEOUS ABRASION TREATMENT FOR STRETCH MARKS Non-Final OA The Children's Medical Center Corporation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month